Medicamen Organics Ltd

MEDIORG NSE Healthcare Pharmaceuticals
₹101.45
-4.96%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Moderate debt: debt-to-equity of 0.5.
  • Promoters hold a majority stake (54.89%).

!Watch-points

  • Thin interest cover: operating profit covers interest only about -5.3 times.
  • Return on equity is on the lower side at -13.7%.
  • Return on capital employed is on the lower side at -10.7%.
  • The company reported a net loss in the latest period.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
1.07

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreWeak
0 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 119 Cr
Current Price₹ 101.45
High / Low₹ 38.00 / 19.10
Stock P/E
Book Value₹ 23.60
Dividend Yield0%
ROCE-10.70%
ROE-13.70%
Face Value₹ 10.00
Debt to Equity0.50
PEG Ratio
EV / EBITDA
Industry PE35.70
P/B Ratio4.18886
EPS₹ -3.30
Debt₹ 14 Cr
PAT Margin-17.76%
Cash PAT₹ -3 Cr
ICR-5.28
Promoter Holding54.89%
FII Holding0.05%
DII Holding0.00%
Public Holding45.05%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Educational data only. Not a recommendation to buy, sell or hold any security.